Study Stopped
no participants enrolled
Analytical Impact of the Transport of Pathological Biological Material by Drone
PATH-AIRCHU
Verification of the Absence of Analytical Impact of the Transport of Pathological Biological Material by Drone Within the Amiens-Picardie University Hospital
1 other identifier
observational
N/A
1 country
1
Brief Summary
The Hospital Group of Territory Somme Littoral Sud, through its biology sector and in partnership with the company DELIVRONE, aims to engage in the experiment of transporting biological samples by means of a drone platform. Transport by air will be between the CHAM, the Abbeville Hospital and the CHU Amiens-Picardie by flying as much as possible over the waterways via the Somme. With a flight speed of around 100km/h at an altitude between 80 and 120 m, drones will be able to connect sites in less than an hour by transporting packages between 2 and 3 kg. Powered by propellers connected to rechargeable batteries, these drones do not emit CO2. This type of transport has not been validated in France by measuring the analytical impact of transport constraints for medical biology, and has never been evaluated according to the criteria of ISO 15189 standard allowing the certification of medical biology laboratories. Validation steps of this transportation method are therefore necessary on pathological samples prior to routine use. The aim of the project is to verify the absence of analytical impact of the transport of pathological biological samples by drone under defined flight conditions, according to the ISO15189 norm.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 22, 2023
CompletedFirst Submitted
Initial submission to the registry
May 24, 2023
CompletedFirst Posted
Study publicly available on registry
June 2, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedOctober 6, 2025
September 1, 2025
3 months
May 24, 2023
September 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
variation of ASAT concentration between both groups
one day
variation of ALAT concentration between both groups
one day
variation of BNP concentration between both groups
one day
variation of LDH concentration between both groups
one day
variation of Glucose concentration between both groups
one day
variation of Troponin concentration between both groups
one day
variation of Potassium concentration between both groups
one day
variation of HIL concentration between both groups
one day
Study Arms (2)
no intervention
drone transportation
Interventions
additional transport of samples at room temperature by drone (departure from the CHU Amiens-Picardie, 1 hour flight in the CHU Amiens-Picardie air perimeter, return to the CHU Amiens-Picardie)
Eligibility Criteria
If eligible for the study, patients from the central blood collection unit and the day hospitals of the CHU Amiens-Picardie will be offered to participate in the study. After information and consent of the patient, blood sampling will be performed to obtain the samples necessary for the normal medical management of the patient, as well as additional tubes corresponding to the same prescribed analyses. The collection of the extra tubes will therefore be done at the same time as the routine collection, without any additional invasive procedure.
You may qualify if:
- Patients admitted to the Amiens-Picardie University Hospital and having benefited from medical biology examinations including the parameters of interest
- according to the usual management modalities and without additional sampling
- at the time of the test period
You may not qualify if:
- Refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens Picardie
Amiens, Picardie, 80054, France
Biospecimen
One supernumerary tube of blood sample for biochemistry analysis
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2023
First Posted
June 2, 2023
Study Start
May 22, 2023
Primary Completion
September 1, 2023
Study Completion
September 1, 2023
Last Updated
October 6, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share